Post-approval studies (Phase 4)Study completedNCT01225237
What this trial is testing
Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc 296